GPCR
Structure Therapeutics Inc - ADR

2,077
Mkt Cap
$3.44B
Volume
909,013.00
52W High
$94.90
52W Low
$13.22
PE Ratio
-19.77
GPCR Fundamentals
Price
$48.59
Prev Close
$50.46
Open
$50.07
50D MA
$71.72
Beta
0.88
Avg. Volume
933,419.40
EPS (Annual)
-$2.39
P/B
2.27
Rev/Employee
$0.00
$2,677.55
Loading...
Loading...

About

Structure Therapeutics, Inc. is a clinical stage global biopharmaceutical company, which engages in developing novel oral therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its pipeline includes Aleniglipron GSBR-1290, ACCG-2671, GIPR, GCGR, ANPA-0073, and LTSE-2578. The company was founded by Raymond C. Stevens in 2016 and is headquartered in South San Francisco, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
220

Frequently Asked Questions

What is Market Cap of Structure Therapeutics Inc - ADR?
What is the 52-week high for Structure Therapeutics Inc - ADR?
What is the 52-week low for Structure Therapeutics Inc - ADR?
What is Structure Therapeutics Inc - ADR stock price today?
What was Structure Therapeutics Inc - ADR stock price yesterday?
What is the PE ratio of Structure Therapeutics Inc - ADR?
What is the Price-to-Book ratio of Structure Therapeutics Inc - ADR?
What is the 50-day moving average of Structure Therapeutics Inc - ADR?
How many employees does Structure Therapeutics Inc - ADR have?

Latest GPCR News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.